TotalMarketCap

Curanex Pharmaceuticals

CURXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$9.064 M

$5.78 +1.23%

Close of 6 Nov 2026

As of 6 Nov 2026, Curanex Pharmaceuticals (CURX) has a market capitalization of $9.06M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$4.23M

Loss-making

Shares outstanding

31,364,812

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #419Phio PharmaceuticalsPHIO$9.29M
  2. #420Moleculin BiotechMBRX$9.16M
  3. #421Curanex PharmaceuticalsCURX$9.06M
  4. #422BullFrog AIBFRG$9.02M
  5. #423BioLineRxBLRX$8.80M

What if Curanex Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$18,005,443

Per share 3,115,129× higher

Bitcoin $1.53T

$974,243.16

Per share 168,554× higher

Apple $5.02T

$3,198,349

Per share 553,348× higher

Or at a round number

$20.0M$50.0M$100.0M$200.0M

Where these numbers come from

Share counts and financials for Curanex Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.